Position in IBIO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$738,252
+$355,389 QoQ
Shares Held
388,554
+95.9% QoQ
Ownership
0.782%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Walleye Capital LLC holds $278,334,962 across 104 Biotechnology names. IBIO ranks #63 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
364,246 | $20,576,256 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
228,593 | $16,975,316 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
87,365 | $16,516,353 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
30,752 | $13,731,998 | |
| 5 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
153,585 | $12,888,853 | |
| 6 | CELC |
Celcuity Inc.
|
105,688 | $12,063,228 | |
| 7 | INSM |
INSMED Inc
|
71,819 | $11,743,842 | |
| 8 | SNDX |
Syndax Pharmaceuticals Inc
|
384,973 | $8,992,969 |
All Filings in IBIO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $738,252 | 388,554 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $382,863 | 198,375 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||